Links and Resources

Research Articles

Twisting and ironing: Doxorubicin cardiotoxicity by mitochondrial DNA damage.

Authors: Nitiss KC, Nitiss JL.
Publication: Clinical Cancer Research
Date: 2014 Sep 15
URL: http://clincancerres.aacrjournals.org/content/20/18/4737.long

Concomitant low-dose doxorubicin treatment and exercise.

Authors: Sturgeon K, Schadler K, Muthukumaran G, Ding D, Bajulaiye A, Thomas NJ, Ferrari V, Ryeom S, Libonati JR.
Publication: American Journal of Physiology Regulatory, Integrative and Comparative Physiology
Date: 2014 Sep 15
URL: http://ajpregu.physiology.org/content/307/6/R685.long

Cancer Treatment–Related Cardiotoxicity: Current State of Knowledge and Future Research Priorities

Authors: Nonniekaye Shelburne, Bishow Adhikari, Joanna Brell, Myrtle Davis, Patrice Desvigne-Nickens, Andrew Freedman, Lori Minasian, Thomas Force, Scot C. Remick
Publication: Journal of the National Institute of Cancer
Date: September 10, 2014
URL: http://jnci.oxfordjournals.org/content/106/9/dju232.full.pdf+html

Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities.

Authors: Shelburne N, Adhikari B, Brell J, Davis M, Desvigne-Nickens P, Freedman A, Minasian L, Force T, Remick SC.
Publication: Journal of the National Cancer Institute
Date: 2014 Sep 10
URL: http://jnci.oxfordjournals.org/content/106/9/dju232.long

Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin.

Authors: Zhu H, Luo P, Fu Y, Wang J, Dai J, Shao J, Yang X, Chang L, Weng Q, Yang B, He Q.
Publication: Oncotarget
Date: 2014 Sep 5
URL: http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=2410

Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.

Authors: van Dalen EC, Raphaël MF, Caron HN, Kremer LC.
Publication: Cochrane Database Systematic Review
Date: 2014 Sep 4
URL: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006647.pub4/abstract;jsessionid=F81C8A1C3D56E949E32D497030C73830.f01t03

Prevention of Anthracycline-Induced Cardiotoxicity: Challenges and Opportunities.

Authors: Vejpongsa P, Yeh ET.
Publication: Journal of the American College of Cardiology
Date: 2014 Sep 2
URL: http://www.sciencedirect.com/science/article/pii/S0735109714043162

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report fromthe American Society of Echocardiography and the European Association of Cardiovascular Imaging

Authors: Juan Carlos Plana, Maurizio Galderisi, Ana Barac, Michael S. Ewer, Bonnie Ky, Marielle Scherrer-Crosbie, Javier Ganame, Igal A. Sebag, Deborah A. Agler, Luigi P. Badano, Jose Banchs, Daniela Cardinale, Joseph Carver, Manuel Cerqueira, Jeanne M. DeCara, Thor Edvardsen, Scott D. Flamm, Thomas Force, Brian P. Griffin, Guy Jerusalem, Jennifer E. Liu, Andreia Magalha˜es, Thomas Marwick, Liza Y. Sanchez, Rosa Sicari, Hector R. Villarraga, and Patrizio Lancellotti
Publication: European Heart Journal - Cardiovascular Imaging
Date: September 2014
URL: http://ehjcimaging.oxfordjournals.org/content/15/10/1063.full.pdf+html

Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology.

Authors: Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M.
Publication: Mayo Clinic Proceedings
Date: 2014 Sep
URL: http://www.mayoclinicproceedings.org/article/S0025-6196(14)00475-3/abstract

Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.

Authors: Nasr M, Nafee N, Saad H, Kazem A.
Publication: European Journal of Pharmaceutics and Biopharmaceutics
Date: 2014 Sep
URL: http://www.ncbi.nlm.nih.gov/pubmed/24813390